| Financial Year |
March 31 2023 |
| Monetary Funds |
3,397,021,137.55 |
| Held-for-trading Financial Assets |
282,793,002.82 |
| Notes Receivable |
4,416,505.68 |
| Accounts Receivable |
3,012,396,537.97 |
| Advances to Suppliers |
2,021,245,317.71 |
| Other Receivables |
963,471,749.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
12,101,222,956.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
15,847,796.04 |
| Other Current Assets |
566,621,028.35 |
| Total Current Assets |
22,365,036,032.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
124,444,301.97 |
| Long-term Equity Investment |
199,167,907.14 |
| Investment Properties |
26,643,044.26 |
| Fixed Assetes |
15,085,536,322.62 |
| Under-construction Projects |
1,277,807,099.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
524,788,271.65 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,635,526,816.67 |
| R&D expenses |
21,815,090.92 |
| Goodwill |
334,221,712.90 |
| Long-Term Deferred and Prepaid Expenses |
182,688,939.34 |
| Deferred Income Tax Assets |
787,658,107.04 |
| Other Non-Current Assets |
306,866,964.87 |
| Sub-Total of Non-Current Assets |
23,175,571,245.98 |
| Total Assets |
45,540,607,278.65 |
| Short-Term Loans |
6,260,735,484.69 |
| Trading Financial liabilities |
69,393,250.06 |
| Notes Payable |
3,407,400,634.23 |
| Accounts Payable |
4,031,875,592.29 |
| Accounts Received In Advance |
7,924,379.45 |
| Employee Compensation Payable |
786,214,922.08 |
| Taxes Payable |
246,243,736.08 |
| Interest Payable |
-- |
| Dividend Payable |
3,279,944.00 |
| Other payables |
495,929,308.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,151,088,103.33 |
| Other Current Liabilities |
549,814,963.27 |
| Sub-Total of Current Liabilities |
19,865,960,510.68 |
| Long-term Loans |
3,868,696,573.66 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
73,606,691.85 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
241,660,954.98 |
| Other Non-Current Liabilities |
105,825.40 |
| Sub-Total of Non-Current Liabilities |
6,145,827,199.22 |
| Total Liabilities |
26,011,787,709.90 |
| Paid-In Capital(Or Share Stock) |
1,663,748,590.00 |
| Capital Surplus |
5,470,138,905.16 |
| Surplus Reserve |
830,580,530.50 |
| LESS:Treasury Stock |
792,321,152.16 |
| Undistributed Profits |
10,928,450,039.41 |
| Minority Stockholder's Interest |
1,241,181,747.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,287,637,820.96 |
| Owner's Equity（Stockholder's Equity） |
19,528,819,568.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
45,540,607,278.65 |
